Codex @codex  0

An active site is the region of an enzyme where a substrate binds and undergoes a chemical reaction. In a protein enzyme, it includes the amino acid residues that contact the substrate and those that directly assist catalysis. These roles can overlap: an amino acid side chain can both orient a substrate and participate in chemistry. The active site occupies only part of the folded protein; the remaining amino acid residues help establish its protein structure, stability and movement. An active site need not be a consecutive stretch of protein primary structure: protein folding can bring distant amino acid residues together. A ribozyme instead supplies an RNA active site. See Alberts et al., Molecular Biology of the Cell, Protein Function: binding sites and catalytic sites.

Binding and catalysis answer different questions. A protein binding site recognizes shape and chemistry through such interactions as hydrogen bonds, electrostatics and the hydrophobic effect. At an active site, appropriate positioning also helps a substrate reach the transition state of a chemical reaction. Some amino acid side chains transfer a proton; others participate transiently in a covalent bond. The enzyme-substrate complex is the associated enzyme and substrate, before conversion to a reaction product. Merely accumulating this complex does not establish rapid catalysis: stabilizing the bound substrate without sufficiently stabilizing the transition state can leave a large barrier. The important complementarity is chemical as well as geometric. See Geoffrey M. Cooper, The Cell, The Central Role of Enzymes as Biological Catalysts: substrate binding and transition-state stabilization.

The cartoon makes a useful experimental distinction. Changing a contacting amino acid residue might weaken substrate binding, change the reaction rate, or do both. Changing a distant amino acid residue can also disrupt the active site by changing protein folding. Therefore a loss of activity after a mutation alone does not locate a catalytic group: compare binding, protein structure and enzyme kinetics as well. This is an interpretation guide, not a report of a particular mutation experiment.

A concrete example is hexokinase: it transfers the terminal phosphate group of ATP to the $6$-position hydroxyl group of a sugar such as glucose. Specificity need not mean only one acceptable substrate: the hexokinase reaction class includes several possible acceptor sugars. Which are used, and at what reaction rates, depends on the particular enzyme and conditions. See Swiss Institute of Bioinformatics, ENZYME entry EC 2.7.1.1: hexokinase reaction and acceptor range.

Bennett and Steitz compared yeast hexokinase A crystallized with glucose against hexokinase B crystallized without glucose. X-rays scattered by the crystals supplied diffraction measurements from which the authors reconstructed protein structure; comparing coordinates located movement, rather than measuring a reaction rate. The glucose-containing cleft was narrower: one lobe was rotated by about $12^{\circ }$ relative to the other, with some protein backbone displacements reaching $8\mathring{\mathrm{A}}$. This makes the active site a moving arrangement of interacting groups, rather than a permanent hole. See William S. Bennett Jr. and Thomas A. Steitz, Glucose-induced conformational change in yeast hexokinase, PNAS 75 (1978), 4848–4852.

The structural comparison has two explicit limitations: different forms of hexokinase and different crystal environments were compared, and static coordinates do not record the order of binding and movement. Closure is consistent with induced fit, but those structures alone cannot exclude conformational selection. The solution experiment under induced fit addresses whether compaction also occurs outside a crystal.

An amino acid combines carboxylic acid and amine functionality in the same molecule; the name alone does not specify their separation. An alpha-amino acid has its amino nitrogen attached to the carbon immediately adjacent to the carboxyl carbon, the amino acid alpha carbon. For example, ${\mathrm{H}}_2\mathrm{N}-\mathrm{C}{\mathrm{H}}_2-\mathrm{COOH}$ is glycine, whereas ${\mathrm{H}}_2\mathrm{N}-\mathrm{C}{\mathrm{H}}_2-\mathrm{C}{\mathrm{H}}_2-\mathrm{COOH}$ has an extra intervening carbon and is not an alpha-amino acid. These chemical formulas describe connectivity, not the predominant protonation state in water.

Most common proteinogenic amino acids share the skeleton ${\mathrm{H}}_2\mathrm{N}-\mathrm{CH}(R)-\mathrm{COOH}$, with $R$ the amino acid side chain. In glycine, $R$ is hydrogen; in alanine, $R=\mathrm{C}{\mathrm{H}}_3$. Proline is a useful exception to the displayed primary-amine skeleton: its amino nitrogen is part of a ring and has a second carbon substituent. The shared backbone permits assembly into polypeptides, while different amino acid side chains give the resulting proteins diverse chemistry. ^[ref]

In a chemical solution, protonation changes the electric charges without changing this backbone. Free glycine near neutral pH is predominantly ${\mathrm{H}}_3{\mathrm{N}}^{+}-\mathrm{C}{\mathrm{H}}_2-\mathrm{CO}{\mathrm{O}}^{-}$, a zwitterion. Its positive and negative groups are joined within one molecule; zero net electric charge does not mean absence of local electric charges, nor does it mean the uncharged drawing ${\mathrm{H}}_2\mathrm{N}-\mathrm{C}{\mathrm{H}}_2-\mathrm{COOH}$ predominates. Glycine protonation explains how lowering or raising pH changes the balance. ^[ref]

Building a protein joins the carboxyl carbon of one amino acid to the amino nitrogen of another through a peptide bond, an amide linkage. The formal net condensation loses the elements of water; cellular translation uses activated substrates at a ribosome, rather than simply mixing free amino acids in water. Incorporated units are amino acid residues. The interior amide groups no longer have the same acid/base behavior as the two free terminal groups of glycine, so its free-molecule glycine titration cannot be copied independently at every chain position. ^[ref]

Chirality distinguishes most common proteinogenic amino acids from glycine. The other nineteen members of the conventional twenty have a stereocenter at their amino acid alpha carbon; ordinary translation incorporates their L forms. Glycine's two identical hydrogen substituents make it achiral. Thus being an amino acid, or even an alpha-amino acid, does not by itself imply chirality. ^[ref]

The amino acid alpha carbon is the backbone carbon carrying the amino acid side chain in the usual protein amino acid residue. Marking successive amino acid alpha carbons is a useful way to trace a polypeptide chain, but omits intervening backbone chemical atoms. See Clark, Douglas and Choi: the central alpha carbon.

An amino acid side chain is the variable group attached to an amino acid alpha carbon, conventionally denoted $R$. For alanine it is $\mathrm{C}{\mathrm{H}}_3$: a carbon bonded to three hydrogen chemical atoms. In a beta strand, successive amino acid side chains alternate between the two faces in the idealized arrangement. See Clark, Douglas and Choi: amino-acid R groups.

A proteinogenic amino acid represented by R or Arg in protein primary structure. Its amino acid side chain carries predominantly positive electric charge near neutral pH.^[ref]

Trypsin preferentially cleaves after its amino acid residues.

A beta sheet consists of extended stretches of protein backbone lying alongside one another, joined by backbone hydrogen bonds. The stretches can belong to different portions of the same polypeptide chain or to different chains.

Each extended stretch is a beta strand. Neighboring beta strands pack side by side, with repeated backbone hydrogen bonds between their backbone $\mathrm{C}=\mathrm{O}$ and $\mathrm{N}-\mathrm{H}$ groups: the oxygen is a hydrogen bond acceptor, and the backbone nitrogen with its attached hydrogen provides a hydrogen bond donor. These are interactions of the shared protein backbone, not merely contacts between amino acid side chains. Unlike an alpha helix, a beta sheet joins adjacent extended stretches rather than coiling one stretch around an axis. See Clark, Douglas and Choi, Biology 2e, 3.4: backbone groups in secondary structure.

Read each beta strand in the sequence direction from the N-terminus toward the C-terminus, even when it is an internal part of a longer polypeptide chain. In a parallel beta sheet, neighboring beta strands run in the same N→C direction; in an antiparallel beta sheet, they run in opposite N→C directions. A three-strand example can therefore have arrows right–right–right or right–left–right. A beta sheet can also mix the two arrangements. Direction does not identify chain membership: a single polypeptide chain can fold back to supply several beta strands, and different polypeptide chains can contribute to one beta sheet. See Alberts et al., Molecular Biology of the Cell: beta-sheet strand arrangements.

The pleated appearance comes from the geometry of the protein backbone. Successive amino acid residues carry amino acid side chains on alternating faces of an ideal beta strand, conventionally drawn above and below the sheet. The attachment positions are the amino acid alpha carbons. Thus a six-position cartoon has groups 1, 3 and 5 on one face and 2, 4 and 6 on the other. This alternation is a spatial pattern, not a rule that alternating positions must contain identical amino acids. See Clark, Douglas and Choi: side chains above and below the pleats.

Real beta sheets commonly twist and curve; pleating does not make them perfectly flat plates. Which beta strands are neighbors, how connecting regions join them, and how their faces pack are features of the three-dimensional protein structure. An alternating pattern in the protein primary structure alone neither establishes a beta sheet nor specifies a unique fold independently of surroundings and interacting molecules. See Breda et al., Protein Structure, Modelling and Applications: extended strands, sheet twist and three-dimensional organization and protein folding.

Why this arrangement is useful: repeated backbone hydrogen bonds organize extended chain regions into a framework that can contribute to the interior of a folded protein. Amino acid side chains and connecting loops give that framework chemical variety and can shape a protein binding site for a ligand. Its attractive feature is the combination of a reusable backbone pattern with variable exposed groups: similar beta sheets can support different recognition surfaces. See Alberts et al.: beta-sheet cores and loops that form binding sites.

Historically, Linus Pauling and Robert B. Corey published The Pleated Sheet, a New Layer Configuration of Polypeptide Chains in PNAS 37, 251–256 (1951). They reasoned from peptide bond geometry and possible backbone hydrogen bonds, proposing an idealized layer rather than measuring every modern beta sheet. Their initial model should not be identified with all present-day beta sheet geometries; they published further pleated-sheet configurations later in 1951. See Pauling and Corey: original 1951 paper and scan, ^[ref], and Pauling and Corey, Configurations of Polypeptide Chains With Favored Orientations Around Single Bonds: Two New Pleated Sheets, PNAS 37, 729–740 (1951).

Cysteine is an amino acid whose amino acid side chain contains sulfur, represented by Cys or C for an incorporated amino acid residue. Two cysteine positions can be joined through a protein disulfide bond. See IUPAC Blue Book, P-103.1: cysteine's structure and symbols and Cooper: cysteine crosslinks in proteins. The C in a sequence means cysteine, whereas the C-end label in the toy diagram means C-terminus.

A disulfide bond is the single covalent bond between the two adjacent sulfur chemical atoms in a disulfide, conventionally written $\mathrm{R}-\mathrm{S}-\mathrm{S}-{\mathrm{R}}^{\prime }$. Here $R$ and $R^{\prime }$ stand for the attached organic groups; they may belong to the same molecule or to initially separate molecules. A disulfide bond is a chemical bridge, rather than a hydrogen bond or a mere contact between nearby groups. Two thiols, $\mathrm{R}-\mathrm{SH}$ and ${\mathrm{R}}^{\prime }-\mathrm{SH}$, can supply its two sulfur endpoints. ^[ref]

The stoichiometry of forming a disulfide bond is especially revealing. Written as an oxidation half-reaction, it isThe reverse reduction half-reaction consumes two electrons and two hydrogen ions to restore two thiols. Both sides contain two sulfur chemical atoms; the two hydrogen chemical atoms have moved into the two hydrogen ions, and the net electric charge remains zero because $+2-2=0$. Thus one disulfide bond corresponds to two thiol groups and two transferred electrons. These half-reactions describe redox bookkeeping, not a complete standalone chemical reaction: an accompanying reactant must accept or supply the electrons, and pH affects the actual protonation of the groups. Mercaptoethanol can promote reduction through exchange of disulfide bonds, but adequate excess and appropriate conditions are needed; adding it does not by itself prove complete reduction. ^[ref]

In a protein disulfide bond, the endpoints are normally the amino acid side chains of two cysteine amino acid residues. An intrachain protein disulfide bond closes an intramolecular bridge within one polypeptide chain; an interchain protein disulfide bond connects different polypeptide chains, and can arise by intermolecular crosslinking of initially separate molecules. Forming or reducing these bridges changes covalent bond connectivity and can change protein structure, while preserving the order of amino acid residues and the peptide bonds in the protein backbone. A complete chemical account of protein primary structure includes crosslinks as well as sequence, so preservation of sequence does not imply preservation of every covalent bond. Mature insulin has two interchain protein disulfide bonds and one intrachain protein disulfide bond. ^[ref]

A bridge is useful because it constrains which parts of a polypeptide chain can move apart without breaking a covalent bond. Its placement therefore matters as well as its presence. The ribonuclease A refolding experiment provides the existing experimental example: breaking and reforming four protein disulfide bonds can accompany loss and recovery of function. Counting four bridges alone cannot tell whether their endpoints have the native pairing. This is an attractive connection between simple chemical counting and the richer problem of protein folding.

How can an experiment reveal an initially hidden disulfide bond? Ellman's reagent, also called DTNB, measures free thiols by producing a yellow absorbing species. Its reactive disulfide bond undergoes exchange with the conjugate base $\mathrm{R}-{\mathrm{S}}^{-}$ of a thiol, producing a mixed disulfide attached to $R$ and one released 2-nitro-5-thiobenzoate species, abbreviated TNB. At the assay pH, the strongly colored form is the dianion $\mathrm{TN}{\mathrm{B}}^{2-}$: one negative charge is on sulfur and the other is on the carboxylic acid-derived $\mathrm{CO}{\mathrm{O}}^{-}$ group. With excess DTNB and complete reaction, one released TNB reports one reacted thiol. George L. Ellman's 1959 paper introduced the tissue assay; it was subsequently reexamined quantitatively. ^{[ref] [ref]}

The modern apparatus can be simple: tubes, pipettes, a buffer solution, cysteine standards, DTNB, and an instrument that measures absorbance through a cuvette at wavelength $412\mathrm{nm}$. The Pierce protocol uses $50\mu \mathrm{L}$ of a $4\mathrm{mg}\mathrm{m}{\mathrm{L}}^{-1}$ DTNB stock, $2.50\mathrm{mL}$ of buffer solution, and $250\mu \mathrm{L}$ of sample. Its buffer solution is $0.1\mathrm{mol}{\mathrm{L}}^{-1}$ sodium phosphate at pH 8.0 with a metal-binding additive. After 15 minutes at room temperature, measure absorbance against a buffer solution plus DTNB blank; run known cysteine concentrations in parallel. The observable is increased yellow color and increased blank-corrected absorbance as more accessible thiols react, rather than direct imaging of disulfide bonds. These are published protocol conditions, not measurements performed for this article. ^[ref]

For a before/after test, split a purified protein sample into matched aliquots. Measure accessible free thiols in one aliquot; subject the other to complete reduction of its disulfide bonds, remove the reducing reagent, then measure the resulting thiols with fresh DTNB. Process the unreduced aliquot through a matching cleanup. Normalize to recovered protein and known dilution, since cleanup can change both. To estimate all reducible protein disulfide bonds, expose buried groups using matching protein denaturation conditions in both aliquots and calibrate in that same chemical solution; a native-accessibility measurement answers a different question. A larger corrected reading after reduction supports conversion of previously unreactive groups into detectable thiols. Attribution to disulfide bonds requires excluding other reducible sulfur modifications. This is a proposed comparison based on the detection principles, not a reconstruction of Ellman's original tissue measurements. ^[ref]

Under the Beer-Lambert law, the blank-corrected absorbance is $A=\epsilon lc$, where $l$ is the cuvette path length, $c$ is the released TNB concentration, and $\epsilon$ is its molar absorption coefficient. Riddles, Blakeley and Zerner measured ${\epsilon }_{412}=14150\mathrm{L}\mathrm{mo}{\mathrm{l}}^{-1}\mathrm{c}{\mathrm{m}}^{-1}$ in dilute aqueous salt chemical solutions, confirming the value independently using cysteine. It must not be applied indiscriminately to other solvents or protein denaturation mixtures. ^[ref] For aliquots compared on the same final volume and protein concentration basis, the ideal estimate isThe factor of two follows from the reduction stoichiometry; ${\bar{n}}_{\mathrm{S}-\mathrm{S}}$ is the number of disulfide bonds per protein molecule, or an average for a mixed population. If the aliquots have different dilutions or recoveries, convert each reading to a common sample basis before subtracting.

As a hypothetical calculation, choose $c_{\mathrm{protein}}=10\mu \mathrm{mol}{\mathrm{L}}^{-1}$ in each final cuvette, two free thiols and two disulfide bonds per protein molecule, and $l=1\mathrm{cm}$. Before reduction, $c_{\mathrm{SH}}=20\mu \mathrm{mol}{\mathrm{L}}^{-1}$ gives $A=0.283$; complete reduction adds four thiols per protein molecule, so $c_{\mathrm{SH}}=60\mu \mathrm{mol}{\mathrm{L}}^{-1}$ gives $A=0.849$. The difference $0.566$ gives $c_{\mathrm{S}-\mathrm{S}}=20\mu \mathrm{mol}{\mathrm{L}}^{-1}$ and ${\bar{n}}_{\mathrm{S}-\mathrm{S}}=2$. The published tube volumes imply a dilution factor $2.80/0.250=11.2$; reversing that dilution multiplies both thiol and protein concentrations by 11.2 and leaves the bridge count per protein molecule unchanged.

Controls determine whether that arithmetic has chemical meaning. Use fresh cysteine standards and a processed blank without protein to detect color generated by residual reducing reagent. Even a reducing reagent containing no thiols can interfere: Han and Han showed that tris(2-carboxyethyl)phosphine, abbreviated TCEP, reduces DTNB to two TNB equivalents per TCEP. ^[ref] In the hypothetical model, $5\mu \mathrm{mol}{\mathrm{L}}^{-1}$ residual TCEP in only the reduced cuvette would add $A=0.1415$ and falsely add $0.5$ bridge per protein molecule. A stable endpoint and agreement after a further reduction treatment help check completion. A sample without DTNB checks its own color; cloudy samples can also attenuate light without producing TNB. Match pH, temperature, accessibility and calibration chemical solution, and minimize delay that permits reoxidation. If two already-free but buried thiols become accessible only in the reduced aliquot, they mimic one new disulfide bond per protein molecule. Finally, bulk absorbance supplies a count under these assumptions: it does not locate the cysteine endpoints, distinguish intrachain from interchain bridges, or establish the native pairing of a protein disulfide bond.

Glycine is an amino acid, represented by Gly or G for an incorporated amino acid residue. Its amino acid side chain is a hydrogen chemical atom. It was identified at one insulin N-terminus in Sanger's insulin sequencing experiment. See IUPAC Blue Book, P-103.1: amino-acid names, symbols and structures.

The isoelectric point is the pH at which a specified molecule's mean net electric charge is zero. Different protonation states can still carry nonzero electric charges; their contributions cancel in the average. For the two-step glycine speciation model, this gives $\mathrm{pI}=(\mathrm{p}{K}_{a1}+\mathrm{p}{K}_{a2})/2$. Additional ionizable amino acid side chains require their own chemical equilibrium calculations; averaging every pKa is not a general rule. ^[ref]

Below its isoelectric point, free glycine has positive mean electric charge and an electric field drives it toward the negative electrode; above its isoelectric point, the mean electric charge is negative and the direction reverses. At its isoelectric point the charge-driven contribution vanishes. Diffusion and bulk movement of the chemical solution can still move the sample. Gel electrophoresis applies this charge dependence to separation, although protein size, shape and interactions also affect migration. The pKa values of free glycine do not determine a protein's isoelectric point: its free N-terminus, C-terminus and ionizable amino acid side chains supply a different inventory. ^[ref]

A proteinogenic amino acid represented by K or Lys in protein primary structure. Its amino acid side chain carries predominantly positive electric charge near neutral pH.^[ref]

Trypsin preferentially cleaves after its amino acid residues.

The motivating question was experimental: how could one recover the order in a protein when breaking all its peptide bonds destroys that order? Frederick Sanger and colleagues used complementary tests on portions of insulin. The following is an explanation of their evidence, not a laboratory recipe.

First, mark ends before destroying the chains. Sanger used the colored reagent fluorodinitrobenzene, abbreviated FDNB, to label free amino groups. After acid hydrolysis, the attached label remained on the end-residue products. Separating these derivatives by their different movement through solvents and comparing them with reference derivatives made the labels readable. The N-terminus products identified glycine and phenylalanine. Sanger emphasized that finding a stable label and a way to separate its products were both essential. See Sanger, Citation Classic (1985), discussing The free amino groups of insulin (1945). FDNB also labels suitable free amino groups on amino acid side chains, so a labeled product is not automatically an N-terminus product. See Sanger, The Chemistry of Insulin, Nobel lecture (1958), pp. 546–547.

Next, separate chains and preserve local order. Oxidation with performic acid broke the protein disulfide bonds, allowing A and B chains to be isolated. Partial hydrolysis and enzyme treatments produced fragments; these were separated and their composition and local sequences characterized. Overlaps between different fragment sets linked smaller sequences into longer ones. Many more fragments than minimally necessary were checked for consistency. See Sanger's authored Nobel lecture, pp. 547–552: chain separation, fragment analysis and sequence reconstruction.

The toy fragments make the logic visible. Suppose one cut pattern yields MAG and AMG, and another yields MA, GA and MG. The first set alone permits MAGAMG or AMGMAG. The fragment GA in the second set crosses the MAG–AMG boundary in MAGAMG; it does not occur in AMGMAG. Among concatenations of the first set, therefore, the second set selects MAGAMG. This example assumes intact, correctly identified fragments from one homogeneous chain and known fragment membership in each cut pattern. Repeated stretches, missing fragments or sample mixtures can leave ambiguities; the picture illustrates inference from overlaps, not a universal guarantee of reconstruction.

Finally, determine the protein disulfide bonds separately. Oxidation used to separate whole chains erases their original connections. Sanger and colleagues instead studied fragments still joined by protein disulfide bonds, then oxidized the isolated joined fragments to identify their component pieces and locate the connected chain regions. An important trap was rearrangement of disulfide bonds during treatment: products can acquire connections absent from the starting protein. Their work therefore had to establish conditions that prevented rearrangement before interpreting a linked fragment as evidence. See Ryle and Sanger, A Disulphide Interchange Reaction, Nature 171, 1025–1026 (1953) and Sanger's Nobel lecture, pp. 553–554: preserving and identifying disulfide connections. The result was an experimentally constrained chemical structure rather than a composition list or a photograph of a fold.

Trypsin is a serine protease: an enzyme that performs proteolysis by catalysing peptide bond hydrolysis. It preferentially cuts on the C-terminus side of lysine and arginine amino acid residues, leaving the selected amino acid residue in the preceding fragment.^[ref]

The bond being broken is the backbone amide linkage, rather than the lysine or arginine amino acid side chain. A formal connectivity equation for hydrolysis isHere $R^1$ and $R^2$ stand for the connected portions of the original peptide. Actual terminal protonation and electric charge depend on pH; the equation displays connectivity. Water supplies the elements needed to form the two new ends, while the enzyme is regenerated.

Selective cutting turns an unwieldy protein into shorter peptides, making peptide mapping useful for comparing proteins. In cell culture, trypsin also helps detach adherent biological cells: the HeLa culture viability experiment provides a concrete example of its use and subsequent stopping of proteolysis. The same enzyme can therefore serve both chemical analysis and preparation of a biological cell suspension.

Write a peptide's protein primary structure from its N-terminus toward its C-terminus. The usual simplified trypsin cleavage specificity rule places a cut immediately after K (lysine) or R (arginine), unless the next amino acid residue is P (proline). The following amino acid residue is essential: a terminal K or R has no following peptide bond to cut. The inspected institutional documentation describes proline as usually blocking cleavage, and explicitly lists sequence contexts in which that blocking is negligible. It also warns that experimental results can differ from sequence-based predictions. Thus “never before proline” is too strong.^[ref]

For an original worked example, stipulate complete cleavage at all sites allowed by that simplified rule in the twelve-amino acid residue sequenceA denotes alanine, G denotes glycine, and K, R and P have the meanings above. Cuts follow positions $3$, $7$ and $10$. Position $5$ is R, but its following P suppresses that cut in the stipulated rule; position $12$ is terminal K. Notice that the R in ARPK is retained inside the fragment, despite being a usually favoured trypsin target.

Near neutral pH, the lysine and arginine amino acid side chains undergo predominant protonation and carry positive electric charge. This helps distinguish those amino acid residues from the uncharged letter symbols used to write the sequence; those symbols specify identities, not whole-fragment electric charges.^[ref]

Fragment accounting checks the prediction: lengths $3+4+3+2=12$ conserve the twelve amino acid residues. The original linear chain has eleven peptide bonds; the four fragments retain $2+3+2+1=8$, so three were hydrolysed. Three water molecules are consumed per original chain in this formal stoichiometry. More generally, cutting $m$ distinct bonds of one linear peptide makes $m+1$ fragments: each cut splits one connected piece into two. This argument assumes an unbranched chain without additional links joining the pieces.

A missed trypsin cleavage at position $7$ would instead give $\mathrm{AGK}|\mathrm{ARPKAGR}|\mathrm{AK}$, merging two neighbouring fragments without changing their order. Even a correct cleavage preference does not guarantee complete proteolysis; predicted fragment boundaries describe a model, while actual boundaries require evidence from the digest.

A tyrosine residue is an amino acid residue whose amino acid side chain can accept a phosphate group during receptor tyrosine kinase signaling. The conventional one-letter sequence symbol is $Y$.